Company / Shareholders' Equity
Beta Bionics, Inc. Shareholders' Equity History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shareholders' Equity
$287.6M
FY2025
5-year range
-$245.4M / $287.6M
FY2023-FY2025
Trend
+217.2%
vs FY2024
Sector context
#130 of 161
Health Care
What the data says
Shareholders' Equity changed +217% YoY in FY2025, a notable deviation from the 2-year average annual change of +98%.
Based on SEC 10-K filings.
$288M in FY2025.
Improved from -$203M to $288M over the past 2 years.
Health Care sector context is included.
Shareholders' Equity over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 19% in Health CareTop 81% of 161This company $287.6M Sector average $5.1B
▼
-94.3% below sector average
Key checks
Key Insights
- In FY2025, shareholders' equity increased 217.2% year-over-year.
- Ranks #130 out of 161 companies in the Health Care sector.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shareholders' EquityValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $287.6M | +217.2% |
| FY2024 | -$245.4M | -20.8% |
| FY2023 | -$203.1M | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026